Related articles:

Acorda Therapeutics Inc.: Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2016
February 14, 2017
February 14, 2017

Acorda Therapeutics Inc.: Acorda Therapeutics to Present at Two Investor Conferences in February
February 03, 2017
February 3, 2017

Acorda Therapeutics Inc.: Acorda to Host Conference Call to Discuss Fourth Quarter 2016 on February 14, 2017
January 31, 2017
January 31, 2017

Acorda Therapeutics Inc.: Acorda Announces 2016 AMPYRA Net Sales and 2017 Financial Guidance at J.P. Morgan Healthcare Conference
January 09, 2017
January 9, 2017

Acorda Therapeutics Inc.: Acorda to Host Conference Call to Discuss Third Quarter 2016 on October 27, 2016
October 17, 2016
October 17, 2016

Acorda Therapeutics Inc.: Acorda Provides Financial and Pipeline Update for Second Quarter 2016
July 28, 2016
July 28, 2016

Acorda Therapeutics Inc.: Acorda to Host Conference Call to Discuss Second Quarter 2016 on July 28, 2016
July 07, 2016
July 7, 2016

Acorda Therapeutics Inc.: Acorda Appoints Burkhard Blank, M.D., as Chief Medical Officer (CMO)
July 01, 2016
July 1, 2016

Acorda Therapeutics Inc.: Acorda Therapeutics to Present at the 37th Annual Goldman Sachs Global Healthcare Conference
May 31, 2016
May 31, 2016

Acorda Therapeutics Inc.: Final Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp.
May 02, 2016
May 2, 2016

Acorda Therapeutics Inc.: Acorda Provides Financial and Pipeline Update for First Quarter 2016
April 28, 2016
April 28, 2016

Acorda Therapeutics Inc.: Acorda Announces Results from Phase 2b Clinical Trial of CVT-301 for Treatment of OFF Periods in Parkinson’s Disease Published in Movement Disorders
April 20, 2016
April 20, 2016

Acorda Therapeutics Inc.: Acorda to Host Conference Call to Discuss First Quarter 2016 on April 28, 2016
April 14, 2016
April 14, 2016

Acorda Therapeutics Inc.: Final Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Commencement of a Subsequent Offer Period
April 13, 2016
April 13, 2016

Acorda Therapeutics Inc.: Acorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 22 March 2016 (Finnish language version)
March 22, 2016
March 22, 2016

Acorda Therapeutics Inc.: Acorda Wins Federal Circuit Appeal Allowing AMPYRA® Patent Litigation to Continue in Delaware District Court
March 21, 2016
March 21, 2016

Acorda Therapeutics Inc.: Acorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 11 March 2016 (Finnish-language version)
March 10, 2016
March 10, 2016

Acorda Therapeutics Inc.: Acorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisory Authority
March 03, 2016
March 3, 2016

Acorda Therapeutics Inc.: Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End 2015
February 11, 2016
February 11, 2016

Acorda Therapeutics Inc.: Acorda to Host Conference Call to Discuss Fourth Quarter and Year End 2015 Results on February 11, 2016
January 28, 2016
January 28, 2016

Acorda Therapeutics Inc.: Acorda Announces 2015 AMPYRA Sales, 2016 Financial Guidance and 2016/2017 Clinical Milestones at J.P. Morgan Healthcare Conference
January 11, 2016
January 11, 2016

Acorda Therapeutics Inc.: Acorda Announces Departure of Chief Medical Officer (CMO); Company Appoints Burkhard Blank, M.D. as Interim CMO
December 21, 2015
December 21, 2015

Acorda Therapeutics Inc.: Acorda Announces Patent Trials and Appeal Board (PTAB) Denies Both IPRs of AMPYRA Patents
August 24, 2015
August 24, 2015

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss Second Quarter Results on July 30, 2015
July 23, 2015
July 23, 2015

Acorda Therapeutics Inc.: Acorda CEO Ron Cohen Named BIO Chairman for 2015-2016 Term
June 15, 2015
June 15, 2015

Acorda Therapeutics Inc.: Acorda Reports First Quarter 2015 Financial Results
April 30, 2015
April 30, 2015

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2015 Financial Results on April 30, 2015
April 23, 2015
April 23, 2015

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2014 Financial Results on February 12, 2015
February 05, 2015
February 5, 2015

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss Third Quarter 2014 Financial Results on October 30, 2014
October 23, 2014
October 23, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Completes Acquisition of Civitas Therapeutics
October 22, 2014
October 22, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics to Acquire Civitas Therapeutics
September 24, 2014
September 24, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Reports Second Quarter 2014 Financial Results
July 31, 2014
July 31, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results on July 31, 2014
July 24, 2014
July 24, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Announces Pricing of $300 Million of 1.75% Convertible Senior Notes Due 2021
June 18, 2014
June 18, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Announces Public Offering of Convertible Senior Notes Due 2021
June 16, 2014
June 16, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
May 14, 2014
May 14, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics Reports First Quarter 2014 Financial Results
May 06, 2014
May 6, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results on May 6, 2014
April 29, 2014
April 29, 2014

Acorda Therapeutics Inc.: Acorda Joins Participants from Around the World in Recognizing Purple Day® to Raise Epilepsy Awareness
March 26, 2014
March 26, 2014

Acorda Therapeutics Inc.: Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2013 Financial Results on February 13, 2014
February 06, 2014
February 6, 2014

Pin It on Pinterest

Share This